{"id":"W2900077869","doi":"10.1016/j.jaci.2018.10.033","title":"Human and computational models of atopic dermatitis: A review and perspectives by an expert panel of the International Eczema Council","year":2018,"lang":"en","type":"review","venue":"Journal of Allergy and Clinical Immunology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"ca_institutions":"Innovaderm (Canada)","funders":"H2020 European Research Council; NIHR Newcastle Biomedical Research Centre; Engineering and Physical Sciences Research Council; Chugai Pharmaceutical; Genentech; LEO Pharma; H. Lundbeck A/S; Beiersdorf; Almirall; Galderma; Astellas Pharma; Mount Sylvia Diatomite; Deutsche Forschungsgemeinschaft; National Institute for Health and Care Research; AbbVie; Glenmark Pharmaceuticals; National Centre for the Replacement, Refinement and Reduction of Animals in Research; Dermira; Bristol-Myers Squibb; Royal Society; Janssen Biotech; Medical Research Council; Medical Research Council Canada; Les Laboratories Pierre Fabre; British Association of Dermatologists; Wellcome Trust; National Institutes of Health; Regeneron Pharmaceuticals; Newcastle University; Kiniksa Pharmaceuticals; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Kyowa Hakko Kirin; Sanofi; Celgene; Novartis; GlaxoSmithKline; British Skin Foundation; Allergan; AstraZeneca; Lundbeckfonden; Eli Lilly and Company; Amgen; Pfizer; Dermatology Foundation","keywords":"Atopic dermatitis; Dermatology; Medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002213193,0.00111341,0.001393316,0.003258314,0.0002737752,0.0013012,0.001449139,0.001585999,0.002628417],"category_scores_gemma":[0.002533094,0.0004541784,0.001016611,0.002323783,0.0005513771,0.001861029,0.0009915838,0.002337524,0.00153483],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007850234,"about_ca_system_score_gemma":0.0021138,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001911309,"about_ca_topic_score_gemma":0.002599608,"domain_scores_codex":[0.9996151,0.0001038067,0.00006957259,0.00005055676,0.0001339222,0.00002695193],"domain_scores_gemma":[0.9983321,0.0009524737,0.00008534024,0.00004971201,0.0005011664,0.00007920597],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005902471,0.0001148891,0.0005394109,0.01509763,0.0001528928,0.0003286315,0.000196902,0.002437169,0.001397448,0.01140885,0.08084214,0.8874249],"study_design_scores_gemma":[0.00001380425,0.0000802229,0.0006836599,0.009531345,0.000151031,0.0009377031,0.0001088988,0.0007425171,0.0006252961,0.005732304,0.9813532,0.00003996717],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002123791,0.9943146,0.001480699,0.001694373,0.0006675489,0.00001755826,0.00004570504,0.00001934002,0.001547784],"genre_scores_gemma":[0.00108591,0.9955637,0.001666696,0.0005191907,0.0003835874,0.00001940375,0.00008095989,0.000009732644,0.0006707946],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003258314,"threshold_uncertainty_score":0.01170462,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1590819198340429,"score_gpt":0.4016575420233192,"score_spread":0.2425756221892764,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}